Objective: To probe into the pharmaceutical practice of anti-infective treatment for neonatal carbapenem-resistant Klebsiella pneumoniae. Methods: Retrospective analysis was performed on anti-infective treatment for a case of neonatal carbapenem-resistant K. pneumoniae participated by clinical pharmacists. Results: In combination with the drug sensitivity test report and the disease condition of the child

the clinical pharmacists participated into the formulation of the anti-infective treatment regimen and provided pharmaceutical care for the child

the infection was controlled and the child successfully discharged from the hospital. Conclusion: In the treatment of carbapenem-resistant K. pneumoniae

clinical pharmacists should take advantages of the expertise and participate into the clinical treatment to improve the safety and effectiveness of drug therapy.